Structural and functional dysbiosis of gut microbiota in Tibetan subjects with coronary heart disease

被引:1
|
作者
Cheng, Qi [1 ,2 ,3 ]
Fan, Chao [1 ,2 ,3 ]
Liu, Fengyun [4 ,5 ]
Li, Yuan [4 ,5 ]
Hou, Haiwen [4 ,5 ]
Ma, Yan [4 ,5 ]
Tan, Yueqing [4 ,5 ]
Li, Yuxian [4 ,5 ]
Hai, Yue [4 ,5 ]
Wu, Tianyi [4 ,5 ]
Zhang, Liangzhi [1 ,2 ]
Zhang, Yanming [1 ,2 ]
机构
[1] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining 810008, Peoples R China
[2] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Anim Ecol Genom, Xining 810008, Peoples R China
[3] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[4] Qinghai High Altitude Med Res Inst, Natl Key Lab High Altitude Med, Xining 810012, Peoples R China
[5] Qinghai Prov Cardiovasc & Cerebrovascular Dis Spec, Xining 810012, Peoples R China
关键词
Coronary heart disease; Gut microbiota; Metagenome; Shotgun; Tibetan subjects; TRIMETHYLAMINE-N-OXIDE; ARTERY-DISEASE; CARDIOVASCULAR HEALTH; EARLY-CHILDHOOD; RISK-FACTORS; LIPOPOLYSACCHARIDE; METABOLISM; OBESITY; ACCUMULATION; HOMOCYSTEINE;
D O I
10.1016/j.ygeno.2022.110483
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The gut microbiota plays a crucial role in coronary heart disease (CHD). However, only a few studies focusing on the relationship between gut microbiota and CHD in ethnic populations are available. Here, we employed shotgun sequencing of the gut metagenome to analyze the taxonomic composition and functional annotation of the gut microbiota of 14 CHD patients, 13 patients with non-stenosis coronary heart disease (NCHD), and 18 healthy controls (HT) in Tibetan subjects. We found that the alpha-diversity of the gut microbiota was not signifi-cantly different among the three groups., whereas beta-diversity was significantly altered in the CHD group compared with HT. Based on the receiver operating characteristic curve (ROC) analysis, the relative abundance of Proteobacteria species effectively distinguished patients with CHD from the control group. Most of the enriched species belonged to Proteobacteria. The pathways that contributed the most to the differences between groups were amino acid metabolism-related pathways, especially lysine biosynthesis. The enzymes of the lysine biosynthesis pathway, including K01714 and K00821, were significantly decreased in the CHD group. Our findings increase the understanding of the association between CHD pathogenesis and gut microbiota in the Tibetan population, thus paving the way for the development of improved diagnostic methods and treatments for Tibetan patients with CHD.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Metagenomics reveals structural and functional gut mycobiota dysbiosis in Tibetan subjects with coronary heart disease
    Cheng, Qi
    Zhang, Liangzhi
    Liu, Fengyun
    Fan, Chao
    Wu, Tianyi
    Li, Yuan
    Hou, Haiwen
    Ma, Yan
    Tan, Yueqing
    Li, Yuxian
    Hai, Yue
    Zhang, Yanming
    [J]. HUMAN GENE, 2023, 36
  • [2] Dysbiosis signatures of gut microbiota in coronary artery disease
    Zhu, Qi
    Gao, Renyuan
    Zhang, Yi
    Pan, Dengdeng
    Zhu, Yefei
    Zhang, Xiaohui
    Yang, Rong
    Jiang, Rong
    Xu, Yawei
    Qin, Huanlong
    [J]. PHYSIOLOGICAL GENOMICS, 2018, 50 (10) : 893 - 903
  • [3] Gut Microbiota Dysbiosis in Functional Dyspepsia
    Tziatzios, Georgios
    Gkolfakis, Paraskevas
    Papanikolaou, Ioannis S.
    Mathur, Ruchi
    Pimentel, Mark
    Giamarellos-Bourboulis, Evangelos J.
    Triantafyllou, Konstantinos
    [J]. MICROORGANISMS, 2020, 8 (05)
  • [4] The Role of the Gut Microbiota in Coronary Heart Disease
    Liu, Huagang
    Zhuang, Junli
    Tang, Peng
    Li, Jie
    Xiong, Xiaoxing
    Deng, Hongping
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (12)
  • [5] The Role of the Gut Microbiota in Coronary Heart Disease
    Huagang Liu
    Junli Zhuang
    Peng Tang
    Jie Li
    Xiaoxing Xiong
    Hongping Deng
    [J]. Current Atherosclerosis Reports, 2020, 22
  • [6] Alterations of Gut Microbiome in Tibetan Patients With Coronary Heart Disease
    Liu, Fengyun
    Fan, Chao
    Zhang, Liangzhi
    Li, Yuan
    Hou, Haiwen
    Ma, Yan
    Fan, Jinhua
    Tan, Yueqin
    Wu, Tianyi
    Jia, Shangang
    Zhang, Yanming
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [7] Dysbiosis of Gut Microbiota and Metabolite Phenylacetylglutamine in Coronary Artery Disease Patients With Stent Stenosis
    Fang, Chen
    Zuo, Kun
    Fu, Yuan
    Li, Jing
    Wang, Hongjiang
    Xu, Li
    Yang, Xinchun
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Dysbiosis of Gut Microbiota in Patients with Chronic Kidney Disease
    Yasuno, Tetsuhiko
    Takahashi, Koji
    Tada, Kazuhiro
    Hiyamuta, Hiroto
    Watanabe, Maho
    Ito, Kenji
    Arima, Hisatomi
    Masutani, Kosuke
    [J]. INTERNAL MEDICINE, 2024, 63 (03) : 347 - 352
  • [9] Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease
    Teramoto, Yoshiki
    Akagawa, Shohei
    Hori, Shin-ichiro
    Tsuji, Shoji
    Higasa, Koichiro
    Kaneko, Kazunari
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis
    Manolis, Antonis A.
    Manolis, Theodora A.
    Melita, Helen
    Manolis, Antonis S.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2022, 29 (23) : 4050 - 4077